Vh. Donaldson et al., AN HMG-I PROTEIN FROM HUMAN ENDOTHELIAL-CELLS APPARENTLY IS SECRETED AND IMPAIRS ACTIVATION OF HAGEMAN-FACTOR (FACTOR-XII), Proceedings of the Association of American Physicians, 110(2), 1998, pp. 140-149
Citations number
31
Categorie Soggetti
Medicine, General & Internal","Medicine, Research & Experimental
A highly purified protein from lysates of human umbilical vein endothe
lial cells (HUVECs) inhibited the activation of factor XII [Hageman fa
ctor (HF)] and removed factor XIIa from an activating surface, thus im
pairing HF-dependent coagulation and kinin-releasing activities. Two t
ryptic peptides from this protein had 100% identity with amino acids 3
1-44 and 89-101 of a nonhistone DNA-binding protein known as high-mobi
lity group protein (HMG-I). In specific antibody experiments, the clot
-inhibiting propel ty in purified lysate protein from HUVECs was assoc
iated with HMG-I. The molecular weight of the protein that inhibited c
lotting was consistent with that predicted for HMG-I. Protein that inh
ibited contact activation and had antigenic properties of HMG-I and HU
VEC lysate protein also was found in conditioned media from unchalleng
ed cultured HUVECs. After HUVECs were incubated with C-14 lysine. cond
itioned media contained immunoprecipitable radiolabeled protein with t
he same molecular weight as that recovered from cell lysates, suggesti
ng that this high-mobility group protein (HMG-I) may be secreted. Puri
fied factor XII antigens were displaced from a glass surface by HMG-I
from lysates in proportion to the amount of HMG-I protein that was add
ed. This HMG-I probably inhibits factor XII functions because its high
positive charge favors competitive binding to an activating substance
.